Llwytho...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Editorial summary Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2018-02-01
|
| Cyfres: | Genome Medicine |
| Mynediad Ar-lein: | http://link.springer.com/article/10.1186/s13073-018-0524-7 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|